‘A wake-up call’: GPs issued warning over semaglutide prescribing The DoHAC has delivered ‘education letters’ to more than 1000 doctors found to be prescribing the medication under the PBS, but failing to follow the criteria.
New guidance on driving and medicinal cannabis The GP-led, practical resources aim to support doctors considering medicinal cannabis treatment for patients who choose to drive.
What is Ryeqo? While the medicine has already been available in Australia since 2022, it was recently approved for the treatment of endometriosis.
‘Unprecedented’ update to antibiotic guidelines The first tranche of a major update from Therapeutic Guidelines has been released, with a focus on infections treated in primary care.
GPs to play key role in ADHD care under landmark reforms The NSW Government has announced significant reforms to improve access to ADHD diagnosis and treatment by expanding the role of GPs.
First no gap fee private hospital opens in Melbourne As the healthcare landscape continues to shift, specific private health insurance holders can visit the hospital with no out-of-pocket costs, but one GP expert says ‘the devil is in the detail’.
Key to bacterial vaginosis treatment unlocked GPs say clinical changes could be on the way after a landmark study confirmed the condition is an STI, with its recurrence halved when a woman’s partner is treated simultaneously.
‘I couldn’t walk’: GP’s personal story of vitamin B6 toxicity Found in listed medicines, energy drinks, cereals and weight loss shakes, some people are consuming more than 50x the recommended daily intake.
TGA issues GLP-1 RA class-wide safety update Product warnings have been updated due to the high-profile treatment’s potential to cause a rare, but severe, form of eye disorder.
‘Convincing’ evidence the pill can cause depression And some types are worse than others, writes psychiatrist Professor Jayashri Kulkarni.